Clinical & Translational Immunology

Papers
(The TQCC of Clinical & Translational Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
107
92
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system52
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease43
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation39
Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients37
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant36
Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐1931
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease27
An optimised whole blood interleukin‐2 release assay is more sensitive than interferon‐γ ELIS pot for detecting and quantifying gluten‐specific 27
26
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine25
25
Effects of extremely preterm birth on cytokine and chemokine responses induced by T‐cell activation during infancy25
Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery24
24
23
Targeting BMI‐1 to deplete antibody‐secreting cells in autoimmunity22
Adeno‐associated viral vectors encoding anti‐P2X7 nanobodies reduce graft‐versus‐host disease in a humanised mouse model21
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation21
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma21
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination20
19
Inhibitory effect of hydroxychloroquine on glucocorticoid‐induced osteoporosis in lupus therapy19
Optimised modular anti‐FLAG CAR T cells for solid tumor therapy19
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease19
Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease18
Siglec‐1, an easy and contributory inflammation marker in rheumatology18
Genome‐wide association study and polygenic risk scores of eosinophilia in Taiwan18
17
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity17
Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients17
17
16
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer15
Skin immunity and inflammation: cellular interactions and communication15
Identification of polo‐like kinase 1 as a therapeutic target in murine lupus15
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models14
Increased amphiregulin expression by CD4+ T cells from individuals with asymptomatic Leishmania donovani infection14
13
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial13
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis13
Human axillary lymph node T follicular helper (Tfh) and Precursor‐Tfh cells exhibit functional flexibility following seasonal influenza vaccination13
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies13
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort13
Data standards for single‐cell RNA‐sequencing of paediatric cancer13
CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer13
13
Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis12
A unique cytotoxic CD4 + T cell‐signature defines critical COVID‐1912
Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis12
Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells12
Pulmonary complications post allogeneic haematopoietic stem cell transplant in children11
Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis11
Effect of washed versus unwashed red blood cells on transfusion‐related immune responses in preterm newborns11
Targeting SARS‐CoV ‐2 infection through CAR‐T ‐like bispecific T cell engagers incorporating 11
Inflammasome activation: from molecular mechanisms to autoinflammation10
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis10
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis9
Long‐term effects of influenza and Bacille Calmette–Guérin vaccination on systemic inflammation9
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival9
9
9
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis9
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients9
Antigen‐specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis8
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis8
Sex‐bias in CD8+ T‐cell stemness and exhaustion in cancer8
Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation8
Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma8
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients8
Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia8
Elucidating novel immune profiles for predicting infection in high‐risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia8
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination8
Understanding the tumor microenvironment in head and neck squamous cell carcinoma8
Genetic differences in the HLA region contribute to the variability in SARS‐CoV‐2 vaccine responsiveness of older persons: the Doetinchem Cohort Study8
0.067346096038818